Edarbi Related Clinical Trials
A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults [Terminated]
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone [Completed]
TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension [Not yet recruiting]
Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients [Recruiting]
Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension [Completed]
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension. [Completed]
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension [Completed]
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension [Completed]
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension. [Completed]
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. [Completed]
Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension [Completed]
Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension [Completed]
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension [Completed]
A Phase 3 Pharmacokinetic Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension [Not yet recruiting]
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension [Completed]
One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Completed]
Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes [Terminated]
A Phase I Bioequivalence Study of TAK-536 Pediatric Formulation [Recruiting]
Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia [Recruiting]
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension [Completed]
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease [Completed]
Effect of Azilsartan on Aldosterone in Postmenopausal Females [Recruiting]
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. [Recruiting]
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus [Terminated]
Azilsartan Circadian and Sleep Pressure [Recruiting]
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering [Completed]
A Phase III Long-term Study of TAK-536TCH in Patients With Essential Hypertension [Recruiting]
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R [Recruiting]
Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes [Terminated]
Azilsartan Tablets Special Drug Use Surveillance: Long-term Use [Active, not recruiting]
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension [Recruiting]
A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet [Completed]
Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey" [Recruiting]
Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance "Hypertension Complicated by Diabetes " [Active, not recruiting]
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension [Recruiting]
Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics [Recruiting]
|
